Urinary Catheters Market 2016 Size, Trends, Growth, Analysis and Forecasts

December 6, 2016, 12:00 am

≫ Next: Orthotic Devices Orthotic Splints and Orthopedic Braces and Support Market Shares, Strategies and Forecast Worldwide, 2015 to 2025

≪ Previous: Biomedical Metal Industry Development Trend 2021 Forecast

(EMAILWIRE.COM, December 06, 2016 ) Urinary catheters are hollow, partially flexible tubes that help collect urine from the bladder. These devices are attached to a drainage bag that collect the urine. They are available in the market in the forms of rubber, plastic, silicone, or latex. The catheter tube is attached to a drainage bag that holds the collected urine. These catheters can be used permanently or temporarily depending on the individuals' health condition.

Publisher's analysts forecast the global urinary catheters market to grow at a CAGR of 5.21% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-urinary-catheters-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of global urinary catheters market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of intermittent catheters, foley catheters, and male external catheters.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Publisher's report, Global Urinary Catheters Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- B. Braun Melsungen
- Coloplast
- Medtronic
- Hollister
- C.R. Bard

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001386163/sample

Other prominent vendors
- Apexmed International
- BioDerm
- ConvaTec
- Cook Medical
- Dileh Medical Supplies
- Laborie
- Poiesis Medical
- Rochester Medical
- Sterimed
- Teleflex

Market driver
- Incidence of urinary incontinence
- For a full, detailed list, view our report

Market challenge
- Potential risks associated with urinary catheters
- For a full, detailed list, view our report

Market trend
- Use of coated urinary catheters
- For a full, detailed list, view our report

Inquire for Report at http://www.reportsweb.com/inquiry&RW0001386163/buying .

Priya Sisodia
+1-646-491-9876
sales@reportsweb.com

Source: EmailWire.Com

↧

Orthotic Devices Orthotic Splints and Orthopedic Braces and Support Market Shares, Strategies and Forecast Worldwide, 2015 to 2025

December 7, 2016, 12:00 am

≫ Next: Paclitaxel Market Research Key Players, Industry Overview, Supply Chain and Analysis to 2016 Â 2021

≪ Previous: Urinary Catheters Market 2016 Size, Trends, Growth, Analysis and Forecasts

(EMAILWIRE.COM, December 07, 2016 ) Orthotic can be defined as the support, brace, or splint used to support, prevent, align, or to correct the functioning of movable body parts such as neck, shoulder, wrist, knee and etc.

These devices are used to change the functioning and structural features of the neuromuscular and skeletal system. The medical field which deals with the design and manufacturing of these devices is known as Orthotics.

The orthotic devices are mainly used to overcome from the traumatic injury, congenital condition or disabling illness. This devices helps the individuals with cerebral palsy, multiple sclerosis, muscular dystrophy, spina bifida and scoliosis, and also for those who are suffering from spinal cord injuries or amputations.

Orthotic Devices - Orthotic Splints and Orthopedic Braces and Support Market: Drivers and Restraints

Presently, orthotic devices global market is driven by the aging population, increasing in the number of incidence of disabilities, growing rate of chronic and lifestyle disease.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-585

Orthotic Devices market is driven by the aging population around the globe, increased focus on improving quality of life, rapid innovations in production and modeling technologies, growing awareness towards orthopedic ailments and rise in sports injuries. However, growing healthcare budget, poor healthcare reimbursement and payment models, and consolidation of market leaders act as a major barrier for the growth of this market.

Orthotic Devices - Orthotic Splints and Orthopedic Braces and Support Market: Segmentation

Orthotic devices market is segmented into following types:

Orthopedic Braces and Support

Upper Extremity Braces and Support

Shoulder Braces and Support

Neck Braces and Support

Elbow Braces and Support

Wrist Braces and Support

Spinal Braces and Support

Low Extremity Braces and Support

Knee Braces and Support

Ankle Braces and Support

Hip Braces and Support

Orthotic Splints

Upper Extremist Splints

Lower Extremist Splints

Orthotic Devices - Orthotic Splints and Orthopedic Braces and Support Market: Overview

With rapid innovations in production and modeling technologies and growing awareness towards orthopedic ailments and rise in sports injuries. The global Orthotic devices market is expected to have a healthy growth rate in the forecast period (2012-2025).

Orthotic Devices - Orthotic Splints and Orthopedic Braces and Support Market: Region-Wise outlook

Depending on geographic regions, global orthotic devices/orthotic splints and braces market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-585

North America held largest share in the global orthotic devices market followed by Europe and Asia Pacific. The developing nations in Asia pacific, Middle East and Africa hold huge potential for growth in the global orthotic device market, owing to developing economies and technological advances

Orthotic Devices - Orthotic Splints and Orthopedic Braces and Support Market: Key Players

Some of the key participating players in the orthotic devices global market are DeRoyal Industries, Otto Bock Holding GmbH& Co., Bauerfeind AG, DJO Inc. and others.

Abhishek Budholiya
2076928790
abhishek.b@futuremarketinsights.com

Source: EmailWire.Com

↧

Paclitaxel Market Research Key Players, Industry Overview, Supply Chain and Analysis to 2016 Â 2021

December 8, 2016, 12:00 am

≫ Next: Petri Dishes Market Research Study including Growth Factors, Types and Application by regions from 2016 to 2021

≪ Previous: Orthotic Devices Orthotic Splints and Orthopedic Braces and Support Market Shares, Strategies and Forecast Worldwide, 2015 to 2025

(EMAILWIRE.COM, December 08, 2016 ) Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Paclitaxel Market Research Report @ http://www.360marketupdates.com/global-paclitaxel-market-by-manufacturers-regions-type-and-application-forecast-to-2021-10384061

Market Segment by Manufacturers, this report covers

· Phyton

· ScinoPharm

· Novasep

· Samyang

· Polymed

· TAPI(Teva) and many others

Scope of the Report:

This report focuses on the Paclitaxel in Global market, especially in North America, Paclitaxel Market in Europe and Asia-Pacific, Paclitaxel Market in Latin America, Paclitaxel Market in Middle and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Regions, regional analysis covers

· North America (USA, Canada and Mexico)

· Europe (Germany, France, UK, Russia and Italy)

· Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

· Latin America, Middle and Africa

Get Sample PDF of Paclitaxel Market Report @ http://www.360marketupdates.com/enquiry/request-sample/10384061

Market Segment by Type, covers

· Natural Paclitaxel
· Semi-synthetic Paclitaxel

Market Segment by Applications, can be divided into
· Ovarian Cancer
· Cervical Cancer
· Breast Cancer
· Other

Key questions answered in the report:
· What will the market growth rate of Paclitaxel market in 2020?
· What are the key factors driving the global Paclitaxel market?
· Who are the key manufacturers in Paclitaxel market space?
· What are the market opportunities, market risk and market overview of the Paclitaxel market?
· What are sales, revenue, and price analysis of top manufacturers of Paclitaxel market?
· Who are the distributors, traders and dealers of Paclitaxel market?
· What are the Paclitaxel market opportunities and threats faced by the vendors in the global Paclitaxel market?
· What are sales, revenue, and price analysis by types and applications of Paclitaxel market?
· What are sales, revenue, and price analysis by regions of Paclitaxel market?

Have Any Query? Ask Our Expert for Paclitaxel Market Report @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10384061

No. of Report pages: 117

Price of Report: $ 3480 (Single User Licence)

About 360 Market Updates:
360 Market Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

Ameya Pingaley
+1 408 520 9750
sales@absolutereports.com

Source: EmailWire.Com

↧

Petri Dishes Market Research Study including Growth Factors, Types and Application by regions from 2016 to 2021

December 8, 2016, 12:00 am

≫ Next: Stretch Socks Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2021

≪ Previous: Paclitaxel Market Research Key Players, Industry Overview, Supply Chain and Analysis to 2016 Â 2021

(EMAILWIRE.COM, December 08, 2016 ) A petri dish is a type of glass or plastic shallow round dish with a close fitting lid which is a vital tool in scientific laboratories. The uses for this piece of equipment are varied, but it is most well-known for holding a culture medium upon which cells, bacteria, and viruses can be grown and studied.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Petri Dishes Market Research Report @ http://www.360marketupdates.com/global-petri-dishes-market-by-manufacturers-regions-type-and-application-forecast-to-2021-10384064

Market Segment by Manufacturers, this report covers

· Corning

· BD

· Thermo Fisher

· Crystalgen

· Greiner Bio-One

· Pall Corporation and many others

Scope of the Report:

This report focuses on the Petri Dishes in Global market, especially in North America, Petri Dishes Market in Europe and Asia-Pacific, Petri Dishes Market in Latin America, Petri Dishes Market in Middle and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Regions, regional analysis covers

· North America (USA, Canada and Mexico)

· Europe (Germany, France, UK, Russia and Italy)

· Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

· Latin America, Middle and Africa

Get Sample PDF of Petri Dishes Market Report @ http://www.360marketupdates.com/enquiry/request-sample/10384064

Market Segment by Type, covers

· Glass Petri Dishes
· Polystyrene Petri Dishes
· Others

Market Segment by Applications, can be divided into
· Laboratory
· Hospital
· Pharmaceutical industry
· Others

Key questions answered in the report:
· What will the market growth rate of Petri Dishes market in 2020?
· What are the key factors driving the global Petri Dishes market?
· Who are the key manufacturers in Petri Dishes market space?
· What are the market opportunities, market risk and market overview of the Petri Dishes market?
· What are sales, revenue, and price analysis of top manufacturers of Petri Dishes market?
· Who are the distributors, traders and dealers of Petri Dishes market?
· What are the Petri Dishes market opportunities and threats faced by the vendors in the global Petri Dishes market?
· What are sales, revenue, and price analysis by types and applications of Petri Dishes market?
· What are sales, revenue, and price analysis by regions of Petri Dishes market?

Have Any Query? Ask Our Expert for Petri Dishes Market Report @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10384064

No. of Report pages: 110

Price of Report: $ 3480 (Single User Licence)

About 360 Market Updates:
360 Market Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

Ameya Pingaley
+1 408 520 9750
sales@absolutereports.com

Source: EmailWire.Com

↧

Stretch Socks Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2021

December 8, 2016, 12:00 am

≫ Next: Global Antidote Market: Impact of Existing and Emerging Market 2016 - 2024

≪ Previous: Petri Dishes Market Research Study including Growth Factors, Types and Application by regions from 2016 to 2021

(EMAILWIRE.COM, December 08, 2016 ) Stretch socks are the medical equipment which is made of a material that has a very high elasticity. Stretch socks can deliver a distributed amount of compression at the ankle and up the leg and help relieve symptoms and slow the progress of varicose veins. They are designed to gently squeeze the legs, which promotes good blood flow in the veins.

Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Stretch Socks Market Research Report @ http://www.360marketupdates.com/global-stretch-socks-consumption-market-by-manufacturers-regions-type-and-application-forecast-to-2021-10384085

Market Segment by Manufacturers, this report covers

· Medtronic(Covidien)

· Sigvaris

· BSN Medical

· Medi

· Juzo

· 3M and many others

Scope of the Report:

This report focuses on the Stretch Socks in Global market, especially in North America, Stretch Socks Market in Europe and Asia-Pacific, Stretch Socks Market in Latin America, Stretch Socks Market in Middle and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Regions, regional analysis covers

· North America (USA, Canada and Mexico)

· Europe (Germany, France, UK, Russia and Italy)

· Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

· Latin America, Middle and Africa

Get Sample PDF of Stretch Socks Market Report @ http://www.360marketupdates.com/enquiry/request-sample/10384085

Market Segment by Type, covers

· Gradient Socks
· Anti-Embolism Socks

Market Segment by Applications, can be divided into
· Ambulatory Patients
· Post-operative Patients
· Pregnant Women
· Others

Key questions answered in the report:
· What will the market growth rate of Stretch Socks market in 2020?
· What are the key factors driving the global Stretch Socks market?
· Who are the key manufacturers in Stretch Socks market space?
· What are the market opportunities, market risk and market overview of the Stretch Socks market?
· What are sales, revenue, and price analysis of top manufacturers of Stretch Socks market?
· Who are the distributors, traders and dealers of Stretch Socks market?
· What are the Stretch Socks market opportunities and threats faced by the vendors in the global Stretch Socks market?
· What are sales, revenue, and price analysis by types and applications of Stretch Socks market?
· What are sales, revenue, and price analysis by regions of Stretch Socks market?

Have Any Query? Ask Our Expert for Stretch Socks Market Report @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10384085

No. of Report pages: 116

Price of Report: $ 3480 (Single User Licence)

About 360 Market Updates:
360 Market Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.

Ameya Pingaley
+1 408 520 9750
sales@absolutereports.com

Source: EmailWire.Com

↧

Global Antidote Market: Impact of Existing and Emerging Market 2016 - 2024

December 9, 2016, 12:00 am

≫ Next: Global Nucleic Acid Labeling Market Headed for Growth and Global Expansion by 2016 - 2026

≪ Previous: Stretch Socks Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) The use of Antidotes is since the early history of medicine. Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes. Most important development are related to the role of antidotes in the management of poisoning cases that have incurred in past few years. Various studies for instances, toxicodynamic and toxicokinetic is expected to help in improving the approach taken for the development and evaluation of antidotes. In addition due to increasing global concern for the effectiveness of antidotes has resulted in the exchange of knowledge, scientific information and clinical experience between health care professionals and scientists from different parts of the world. The evolution of antidotal therapy has been characterized with the help of new antidotes such as monoclonal antibodies, also by accurate scientific approach for the effectiveness and the complications that may occur, by novel applications of existing pharmaceuticals, and by increased cooperation and collaboration at global level.

View Sample Report @ http://www.persistencemarketresearch.com/samples/12439

According to the World Health Organization (WHO) it is projected per year there more than 5 Mn people globally are bitten by snakes, out of which around 100,000 develop severe sequelae. In India mortality is around 30,000 and in the U.S. it was around 50,000 cases of bites out of which 7,000 cases were by venomous snakes. Some key factors such as rising awareness and studies that are conducted for development in identifying toxins in venom bites that by government and companies for better knowledge of these drugs and antidotes is likely to drive the growth of antidote market over forecast period. Identification of snakes is highly important so as to know whether it is snake- specific anti-venoms which are less hazardous as compared to polyvalent anti-venoms. However antidote market has some restraints such as low product of anti-venoms due to rising prices of anti-venoms repressed demand resulting the treatment has declined significantly or even disappeared in some areas is expected to hinder the growth of the antidote market.

Rise in the incidence of snake bites is expected to boost the antidote market over the forecast period. In addition with better awareness among general population, significance of this condition and better understanding of these antidotes is expected to drive the antidote market during the forecast period.

Geographically the antidote market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/12439

MEA followed by Asia Pacific is dominating the antidote market as high number of cases found in these regions. According to WHO in Africa there are around 1 Mn snake bites annually with 50,000 in need of treatment, 25,000 deaths and another 25,000 permanent disabilities. This is majorly due to poor reliable reporting system in these regions and failure to report the injury to health care facilities, these numbers are uncertain. In Asia Pacific region the antidote market is expected to deliver significant growth owing to high population density and extensive agricultural activities, this is expected to boost the demand for antidote market over the forecast period. However unsatisfactory market growth in the region such as Latin America owing to lack of functional snake bite control programs and snake bite management is unsatisfactory in this region. North America and Europe is expected to deliver healthy growth due to increasing knowledge of snake venoms' composition, sufficient product of anti-venoms and better knowledge of clinical features of envenoming.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Global Nucleic Acid Labeling Market Headed for Growth and Global Expansion by 2016 - 2026

December 9, 2016, 12:00 am

≫ Next: Global Sleep Disorder Therapeutics Market Headed for Growth and Global Expansion by 2015 - 2021

≪ Previous: Global Antidote Market: Impact of Existing and Emerging Market 2016 - 2024

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Nucleic acid labeling techniques has wide range of applications in Life sciences industry. Nucleic acid Labeling is mainly used to identify proteins, DNA and RNA by using various Labeling techniques. Currently multiple labels are available in the market for specific applications. Proper labeling technique strategy is the key to identify the specific molecules. Previously, market is more dominated by radioactive Labeling techniques. However, because of the safety concerns radioactive techniques are less preferred. Hence, non-radioactive Labeling techniques gaining traction to identify molecules specifically owing to their highly sensitive and safety concerns. In the non-radioactive category, Chemiluminescent and chemifluorescent techniques has replaced the use of radioactive molecules to identify the antibodies. Various companies are involved in developing the novel nucleic acid Labeling test kits for various applications. Majorly diagnostic companies are actively involved in developing the nucleic acid test kits. The nucleic acid Labeling is mainly dominated by the bigger players than medium and small players

View Sample Report @ http://www.persistencemarketresearch.com/samples/12430

With increase in healthcare expenditure, personalized healthcare treatments, increase in Research and development expenditure and rise in research activities specifically in genomic research and disease diagnosis are the factors fueling growth of this market during the forecast year. However, less skilled professionals and costly process are the major factors hindering the growth of this market.

Based on the product, the market was segmented into reagents and kits and Services. Among them, reagents and kits market will have the largest market share than the services due to their use in various diagnostic and research centers. Furthermore, increase in R & D expenditure also boosts the market during the forecast year.

Based on the application, major market share was dominated by the DNA sequencing technique. It has many applications in identification of genetic disorders, tumors genetic variations and much more are fueling the growth of this market during the forecast period. In addition to that, increase in R & D projects are also one of the factors driving the growth of this market. Companies are interested in developing new generation DNA sequencing techniques that can provide rapid and efficient genomic sequencing than the conventional sequencing

On the basis of end user, nucleic acid Labeling market is segmented into Diagnostic centers, Research centers and Hospitals. Research centers occupies the major market share owing to increase in funding by government organizations to increase research activity and for the drug discovery purposes. Few companies are launching specific reagents and kits that can be used specifically for research purpose this shows the significance of the research centers impact in this nucleic acid labeling market

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/12430

Depending on the geographic region, nucleic acid Labeling market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America accounts the major market share because of increase in personalized medicines, identifying the genetic modifications and therapeutic areas are the factors contributing the growth of this market during the forecast period. In future, emerging markets like China and Brazil are expected to have significant growth by the end of the forecast period.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Global Sleep Disorder Therapeutics Market Headed for Growth and Global Expansion by 2015 - 2021

December 9, 2016, 12:00 am

≫ Next: Throat Lozenges Market Revenue Predicted To Go Up by 2015 to 2021

≪ Previous: Global Nucleic Acid Labeling Market Headed for Growth and Global Expansion by 2016 - 2026

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Sleep disorders include a variety of complications related to sleep and have a high prevalence across the globe. Based on these complications, sleep disorders can be classified into three categories- lack of sleep which includes insomnia, excessive sleep which includes narcolepsy and disturbed sleep which include sleep apnea and Rapid eye movement (REM) disorder. Insomnia may arise as result of unhealthy diet, emotional dreams, stress, and many other factors. Insomnia may affect reaction time towards common stimulus, hand-eye coordination, memory, and disturb daily life. Narcolepsy is a disorder that causes uncontrolled sleep at time period lasting less than minute or more than an hour. It has also been found that patients with narcolepsy experience sleep attacks more often during pregnancy, stress or ill health. Usually narcolepsy is a genetic disease, but it has also been found to develop as a result of some neurological disorders or severe brain damage. REM sleep behavior disorder involves abnormal behavior in sleep. In this disorder, a patient dreaming about running, may run while still asleep. Sleep apnea is obstructed breathing during sleep.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5714

According to a press release in March 2014 by World Association of Sleep Medicine, 45% of the global population suffers from some form of sleep disorder. It also mentions that approximately 25% male and 10% females in the U.S. suffer from sleep apnea. This high prevalence suggests an opportunity for a large therapeutics market.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5714

Currently marketed drugs include Sanofi-Aventis manufactured Ambien (zolpidem), Sunovion Pharmaceuticals Inc.s Lunesta (eszopiclone), Takeda Pharmaceuticals Rozerem (ramelteon), Somaxon Pharmaceuticals, Inc.s Silenor (doxepine) and various others. Over-the-counter drugs are also available for treating sleep disorder; these include Nytol, Sominex, Compoz, and Unisom. Mercks Suvorexant drug is an orexin receptor agonist which is under Phase III trial. Other companies involved in the drug development of sleep disorder include Vanda Pharmaceuticals, Eli Lilly, GlaxoSmithKline and Neurim Pharmaceuticals.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Throat Lozenges Market Revenue Predicted To Go Up by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: European Injectable Drug Delivery Market Revenue Predicted To Go Up by by 2015 to 2021

≪ Previous: Global Sleep Disorder Therapeutics Market Headed for Growth and Global Expansion by 2015 - 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Throat lozenges, commonly known as cough sweet, cough drop, cachou or troche, are small sized medicated tablets. Lozenge word is used for diamonds that are rhombus in size. Throat lozenges are diamond shaped and these tablets get easily dissolved in the mouth and help relieve temporarily from coughs and other throat problems. It helps soothe and lubricate tissues of throat that are affected from influenza or common cold. Throat lozenges are utilized since ages (1000 BC) for treating throat infection. The first throat lozenges were made in Egypt with the utilization of various ingredients such as honey, herbs, citrus and spices. These tablets were further modified by Smith Brothers in 1852 as cough drops and in 1879 by Luden. The modification included the addition of heroin and morphine in small quantity to enhance the efficiency of the actions of throat lozenge.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5726

In current scenario of the market throat lozenges are composed of an anesthetic, benzocaine and eucalyptus oil. Pectin or zinc gluconate glycine is utilized while manufacturing non-menthol throat lozenges. Most of the throat lozenges also contain dextromethorphan. Various brands are available in the market for throat lozenges that include CÄpacol, Butter-Menthol, Chloraseptic, Gorpils, Fisherman's Friend, Halls, Lockets, Läkerol, Pastilles Juanola, Luden's, Ricola, Robitussin, Strepsils and Smith Brothers. Some other brands are Tunes, Vigroids, Vicks, Victory V, Sucrets and CVS Throat Drops.

Throat lozenges are advised to patients suffering from pharyngitis (sour throat). Pharyngitis may be caused due to either virus or bacterial infection (streptococcus infection). It is opined by the medical professionals that approximately 50% of sore throat is caused by viral infections and 15% to 20% occurs due to bacterial infections. Mycoplasma pneumoniae, Streptococcus, Neisseria gonorrhoeae and Chlamydia pneumonia are some of the bacteria that cause sore throat. Symptoms that occur in a patient suffering from sore throat include redness of throat, swollen throat and difficulty in swallowing.

The growth of the market for throat lozenges will be driven by aging population since elderly people often suffer from throat infection that increase the uptake of throat lozenges. It has been projected by the World Health Organization (WHO) that by 2050 nearly 2 billion populations will belong to geriatric population and it also estimated that global elderly population was 524 million in 2010. Similarly, increasing number of HIV patients across the globe also propels the growth of throat lozenges market since HIV patients usually suffer with throat infection. Similarly, rising incidences cold and coughs will also augment the growth of throat lozenges market. In addition, changing lifestyle will further support the growth of throat lozenges market since new lifestyle is responsible for reducing immunity of the body.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5726

North America in 2012, accounted for the largest share of global throat lozenges market due to presence of large number of throat lozenges manufacturers. Also, due to cold temperature in the nations such as U.S. and Canada, accentuate the incidences of cold and cough in population and in turn boost the growth of throat lozenges market in the region. Europe accounted for the second largest share of the global throat lozenges market owing to the presence of large geriatric population. Asia-Pacific and Rest of the World accounted for the smallest share of global throat lozenges market. The major players operating in the throat lozenges market include GlaxoSmithKline Pharmaceuticals Limited, SSL International, Thornton & Ross, Pfizer, Inc. and Procter & Gamble (P&G) amongst other significant players worldwide.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

European Injectable Drug Delivery Market Revenue Predicted To Go Up by by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Traumatic Brain Injury Therapeutics Market Revenue Predicted To Go Up by 2015 to 2021

≪ Previous: Throat Lozenges Market Revenue Predicted To Go Up by 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Injectable drug delivery is a method of drug administration inside a body with the help of needle through various route such as intravenous, intramuscular, or direct injection. The drug used in injectable drug delivery is usually in powder or crystal form. Injected drugs are majorly used in health care for diagnosis, treatment, and prevention of various diseases. Injectable drug delivery is preferred over oral dosage form in emergency conditions due to less time taken by the drug for absorption and metabolization. According to the World Health Organization (WHO), an ideal injection should not pose any risk or harm to the recipient, and also does not produce any waste dangerous to the community. Traditionally, injectables were majorly designed for delivery of human growth hormones, and insulin. However, technological advancements expanded the application of injectables for the delivery of various drug classes such as serotonin antagonists, anticholinergic, reproductive hormones, dopamine agonists, parathyroid hormones, sympathomimetic, hematopoietic, and immune modulators.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5741

European injectable drug delivery market could be majorly segmented by product type, usage, route of administration, and region. Based on product type European injectable drug delivery market could be further segmented into formulations and devices. Formulations for injectables can be further sub divided into conventional drug delivery formulations, new drug delivery formulations, and long-acting formulations. Devices segment can be classified into conventional injectable devices, self-injection devices, and others (microneedles, nanoneedles, and blunt needle injection). Based on the usage, drug injectable drug delivery market could be categorized into curative care, immunization, and other. Depending on the route of administration, the European drug injectable market could be segmented into intravenous, intraperitoneal, subcutaneous, and intramuscular. Geographically, the European drug injectable market segmented into Germany, France, Spain, U.K., Italy, and rest of Europe. At present, on the basis of product type formulation types accounted for the largest share of the market and is expected to dominate the market during the forecast period. increasing prevalence of chronic diseases, the growth of biologics market, technological advancement, and a decrease in side effects offered by formulations are the major factors anticipated growing the formulations market. In devices segment, the industry is witnessing a shift towards self-injectable devices and is estimated to be the fastest-growing segment. Self-injectable devices include pen injector and auto injector are gaining importance as they offer fewer side effects. Geographically, Germany dominated the European drug injectable market followed by France in 2014 due to patient compliance, increasing demand for self-injectable devices, advancement in technology, and the presence of key players in Germany.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5741

European drug injectable market growth is being fuelled by favorable reimbursement policies, rising incidence of cancer, HIV, and diabetes, and increasing patient compliance with injectables. Additionally, entry of newer injectable drugs in the market during the forecast period is expected to propel the market growth. For instance, in March 2015, Novo Nordisk received a marketing approval from the European Commission for Saxena, a drug intended to treat obesity. According to the WHO, obesity affected 39% of adults in 2014. Thus, the market is expected to grow based on above mentioned factors. However, safety concerns, pain associated with injections, risk of blood born infections, and availability of alternative delivery methods such as oral and transdermal are key reasons anticipated to restraint the growth of the European drug injectable market. According to European Centre for Disease Prevention and Control (ECDC), people who inject the drugs (PWID) are at increased risk of HIV infection in Europe. For instance, in 2012 prevalence of HIV was observed 5% or more among PWID in 19 countries of Europe such as Spain, France, Switzerland, and Italy. Hence, the safety is a major issue related to an injectable drug which might restraint the market growth.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Traumatic Brain Injury Therapeutics Market Revenue Predicted To Go Up by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Clinical Information System Market Global Industry Analysis and Forecast Till 2025

≪ Previous: European Injectable Drug Delivery Market Revenue Predicted To Go Up by by 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Traumatic Brain Injury or TBI is sustained from severe or mild damage to the brain tissue from accidents or assaults. In North America, over 1.7 million people suffer annually from TBI and the consequent medical care costs exceed USD 70 billion. According to WHO, the global incidence for TBI is close to 10 million people annually. Brain tissue has one of the least self-repair capabilities making it highly vulnerable to injuries and often leading to permanent loss or disability of motor functions which dramatically reduces the quality of life for any individual. Most neuronal damage occurs sometime after the injury takes place giving a chance for a therapeutic intervention. The previous intervention with Glucocorticoids is not considered due to their harmful effects.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5744

A major challenge in developing therapeutics for TBI lie in overcoming the blood-brain barrier while delivering drugs. In May 2013, DARPA awarded USD 6 million to develop nanotech therapy for combating TBI to a team from University of California San Diego. Nanotechnology offers chances to overcome this physiological challenge of blood-brain barrier to deliver therapeutics. These porous silicon nanoparticles can carry a significant drug load through the blood brain barrier to treat TBI in patients. Other potential treatments include stem cell therapy for CNS trauma and use of apoE-mimetic compounds. Cognosci, a privately held start-up from North Carolina, U.S. has novel therapeutic compounds in pipeline for the treatment of TBI which the company expects to launch in coming years with a strategic partnership alliance. Currently there are two notable clinical trials for gauging the capability of progesterone for traumatic brain injury. The ProTECT III (progesterone for traumatic brain injury) is currently conducted by the Emory University and is sponsored by the NIH. The study has recruited patients from 31 TBI clinical centers across the United States. SyNAPSe, initiated by BHR, a branch of Besins Pharma, in collaboration with the American Brain Injury Consortium (ABIC) and the European Brain Injury Consortium (EBIC), is another Phase III study investigating the efficacy and safety of progesterone in patients with severe traumatic brain injuries.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5744

Since there are currently no approved therapeutic products, the sector is teeming with opportunities for new entrants as well as stalwarts of the pharmaceutical industry. Some of the notable companies developing therapeutics for TBI are Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, NeuroScience Pharmaceuticals and Targacept. Increasing incidences of TBI due to rising assaults, accidents and military combats over the world are expected to drive the growth of the market.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Clinical Information System Market Global Industry Analysis and Forecast Till 2025

December 9, 2016, 12:00 am

≫ Next: Global Travel Vaccines Market : Impact of Existing and Emerging Market 2015 to 2021

≪ Previous: Traumatic Brain Injury Therapeutics Market Revenue Predicted To Go Up by 2015 to 2021

(EMAILWIRE.COM, December 09, 2016 ) Clinical information system (CIS) is a computer aided system that organizes, stores and double checks all the medical information of patient. Clinical information system is designed to provide and improve clinical quality and care for each patient every time. Clinical information system replaces the paper charts such as patient health history, prescriptions, doctor's notes and dictation and all other information of patient in the form of electronically preserved data. Clinical information system reduces the chance of errors because it is required to enter the accurate information of patient. Clinical information system are used in various forms such as electronic medical records (EMR), computerized physician order entry, laboratory information systems, pharmacy information systems, radiology information systems, and PACS. Apart from this clinical information system helps by computerization of repetitive tasks, providing high accuracy, automated recording of medical equipments observations and results. Currently Clinical information system is integrated into ambulatory care records, mobile monitoring solutions, handheld devices for collecting and reviewing data, decision tools and support programs. Clinical information system also facilitates healthcare organizations to participate in Health Information Exchanges (HIEs) to share patient data between health systems.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1018

Clinical Information System Market: Drivers & Restraints

Global clinical information system market is witnessing high growth due to increasing prevalence and incidences of several critical diseases which have increased the burden on clinics and hospitals to diagnose and treat more number of patients with high level of efficiency and accuracy. Major drivers for the global clinical information systems market are technologically advanced and growing number of state of art healthcare facility centers across the globe. Currently demanding CIS such as advanced voice recognition and the ability to record data in structured formats, greater use of mobile devices directly at the point of use as well the use of e-health records that provide a life-time view of a patients health history are rapidly increasing the demand for clinical information systems. At the same time, government incentives to adopt greater use of CIS and demand for enhancement of clinical quality and patient safety, improvement of operational performance or decision making are booming the global clinical information system market. However rapidly changing technology, financial limitations due to low awareness levels and high cost involved in installation and maintenance of clinical information systems and requirement of professional training to handle CIS can hamper the market growth over the forecast period.

Clinical Information System Market: Segmentation

The global clinical information systems market is classified on the basis of geography, end use, type, delivery mode and product.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1018

Based on end use, the global clinical information system market is segmented into the following:

Hospital
Outpatient/Outside Hospital
Business Office
Based on type, the global clinical information system market is segmented into the following:

Hardware
Software
Services
Based on delivery mode, the global clinical information system market is segmented into the following:

On-premises
Cloud based
Based on product type, the global clinical information system market is segmented into the following:

Computerized Physician Order Entry (CPOE) system
Laboratory Information System (LIS)
Radiology Information System (RIS)
Pharmacy Information System (PIS)
Picture Archiving and Communication System (PACS)
Electronic Medical Records (EMR) System
Clinical Information System Market: Overview

Europe and North America are the important markets for clinical information system. In Europe, mainly Germany, France, Netherlands, Spain and the U.K. are estimated to account for a major share of the Western Europe clinical information system market over the forecast period. The developing countries such as India and China are growing with a higher CAGR compared to other countries of the world. By end use, hospitals and outpatient/outside hospital segments held half the share in the global clinical information system and the trend is forecast to continue through 2025. Based on delivery mode, both on-premises and cloud based services are expected to register a substantial CAGR through the forecast period. Based on product type, electronic medical records system and picture archiving and communication systems are the dominant segments globally among other clinical information product types due to its integration facility that transfers medical observations to a remote viewer.

Clinical Information System Market: Key Players

The global clinical information system market key players are Epic, Infermed, Cerner Corporation, Lifecom, Theradoc, iMDsoft, Allscipts, Eclinicalworks, GE Health care, NEXTGen, GreenWay, athenahealthy, Inc., Practice Fusion, Inc., Mednet, Healthland, Iatric Systems, Inc., Clinicmaster, Quintiles, Accenture, Allegro CTMS, Thermo Fisher Scientific Inc., Surgical Information Systems LLC.

Abhishek Budholiya
2076928790
abhishek.b@futuremarketinsights.com

Source: EmailWire.Com

↧

Global Travel Vaccines Market : Impact of Existing and Emerging Market 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Global Trigeminal Neuralgia (TN) Therapeutics Market: Impact of Existing and Emerging Market 2015 to 2021

≪ Previous: Clinical Information System Market Global Industry Analysis and Forecast Till 2025

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Health related complications are greater in developing countries and rural areas because of dissimilarities in sanitary conditions, available food and water bases. The immunization Practices Advisory Committee of the Center for Disease Control and Prevention (CDC) mentions that travelers should be up-to-date on routine immunizations, irrespective of travel plans. The target population for the travel vaccines market include outbound travelers. The travel vaccines for the prevention of hepatitis A, hepatitis B, yellow fever, tetanus, poliomyelitis, meningococcal disease, typhoid fever are manufactured by leading market players namely Sanofi Pasteur, Merck, Novartis and GlaxoSmithKline. Among these aforementioned companies, Sanofi Pasteur and GSK are the notable players in the travel vaccines market that accounts for approximately 85% of total market. Recently in March 2014, Sanofi Pasteur, the vaccines segment of Sanofi announced its long term strategic collaboration with SK Chemicals Company to develop pneumococcal conjugate vaccine (PCV).

View Sample Report @ http://www.persistencemarketresearch.com/samples/5753

The driving factors for the growth of this market include increase in awareness about vaccine preventable diseases and rise in global travel traffic. Moreover, innovation of novel vaccine technologies and technological advancements towards molecular genetics is further boosting the growth of market in coming years. However, requirement of expertise for the production of vaccines and unfavorable healthcare funding towards vaccination could pose a challenge for the growth this market.

Geographically, North America will be the leading market for global travel vaccines market, followed by Europe and Asia-Pacific. The major contributing factors for North America to lead the market include involvement of large number of companies in the production of vaccines and introduction of superior range of vaccines in the market. However, Asia-Pacific market is forecast to grow at a significant growth rate in coming years.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5753

The leading players of this market include GlaxoSmithKline, Sanofi Pasteur, Merck, Novartis, and Pfizer. Other key participants of this market include ALK Abelló A/S, Bavarian Nordic A/S, Crucell N.V., CSL Ltd. Medimmune Inc. and Vaxin Inc.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Global Trigeminal Neuralgia (TN) Therapeutics Market: Impact of Existing and Emerging Market 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Global Unstable Angina Therapeutics Market: Headed for Growth and Global Expansion by 2015 to 2021

≪ Previous: Global Travel Vaccines Market : Impact of Existing and Emerging Market 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Trigeminal neuralgia occurs when the functioning of the trigeminal nerve is disrupted due to damage of the nerve. Trigeminal neuralgia is a chronic condition resulting in intense and extreme pain in the face and is more common among females. The incident represents electrical shock-like feeling and lasts from few seconds to minutes. The etiology of trigeminal neuralgia includes compression of blood vessels, degeneration of arteries, myelin sheath infiltration and idiopathic. Trigeminal neuralgia is most commonly seen after the age of 40 years. Diagnosis of trigeminal neuralgia includes dental pathology diagnosis, temporal arteritis diagnosis, disorders of myelin diagnosis, tumor in posterior fossa diagnosis and migraine diagnosis. Treatment for trigeminal neuralgia includes anticonvulsants or painkiller drug and surgery. There are various types of surgical procedures available for trigeminal neuralgia such as rhizotomy, stereotactic radiosurgery, microvascular decompression, transcutaneous electrical nerve stimulation and acupuncture.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5759

With the rising geriatric population the market for trigeminal neuralgia therapeutics is experiencing a significant growth worldwide as geriatrics are more prone to get this disease. Moreover, technological advancements in diagnostic tests and growing public awareness about the disease also drives the growth of trigeminal neuralgia therapeutics market globally. However, technical complexities associated with existing diagnostic tests and surgeries associated with trigeminal neuralgia might hinder the market growth during the study period.

Geographically, North America and Europe dominates the global market for trigeminal neuralgia therapeutics due to increased awareness among people about trigeminal neuralgia. However Asia-Pacific accounted as an emerging market in trigeminal neuralgia therapeutics owing to its large number of population. RoW is considered as an untapped market in trigeminal neuralgia therapeutics.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5759

Various key players contributing to the global trigeminal neuralgia therapeutics market comprises Abbott Laboratories, Beckman Coulter/Danaher, bioMerieux, Bio-Rad Laboratories, Inc., Bio-Rad, Life Technology, Novartis Diagnostics and Ortho-Clinical Diagnostics.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Global Unstable Angina Therapeutics Market: Headed for Growth and Global Expansion by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Revenue Predicted To Go Up by 2015 to 2021

≪ Previous: Global Trigeminal Neuralgia (TN) Therapeutics Market: Impact of Existing and Emerging Market 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Angina is a condition characterized by the pain in chest, neck, shoulders or arms mainly caused due to blockages in heart arteries due to which heart is deprived of oxygen. There are two major types of angina namely unstable and chronic stable angina. Chronic stable angina also known as angina pectoris is a common form of chest pain caused due to lack of oxygen supply to the heart. It usually occurs during rigorous exercise and pain is alleviated when the person rests for some time. Whereas, unstable angina is a chest pain that occurs suddenly and becomes worse with time. This type of chest pain occurs without cause and can lead to heart attack. Patients with unstable angina needs emergency treatment involving hospitalization and medications that helps in stabilizing the condition. Atherosclerosis (plaque deposition in the arterial walls) is the principal cause of unstable angina. Diagnosis of unstable angina is facilitated by blood tests, echocardiogram (ECG), coronary angiography and echocardiography.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5837

Treatment options depends on the severity of the condition; primary medication options include the use of blood thinners such as heparin or clopidogrel. Also, medications are administered to reduce the angina symptoms such as blood pressure, arrhythmias, cholesterol, anxiety and others. If there is a blockage or narrowing of artery, then the physician may recommend invasive procedures such as angioplasty and in severe cases, heart bypass surgery is recommended. Unstable angina therapeutics market exhibit immense growth potential majorly due to increasing number of patients with cardiac disorders, increasing use of tobacco, improper food habits and changing lifestyles.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5837

Unstable angina therapeutics market can be analyzed on the basis of several products used in treatment of the same. Some of the products used in the treatment are calcium channel blockers, low molecular weight heparins, nitrates, statins, angiotensin-converting enzyme inhibitor, beta blockers and others. Also, a pipeline analysis of unstable angina therapeutics can be elucidated. The major factors influencing the growth of the market are rise in number of patients undergoing treatment for unstable angina and approval of novel therapies that render high safety and efficacy. Rivaroxaban, varespladib and otamixaban are few examples of novel therapeutics that are currently in the late stage of clinical development. These products if approved are expected to be marketed at premium prices. However, low penetration of novel therapies in generics-dominated market would decelerate the growth of unstable angina therapeutics market. Other factors such as patent expirations and high cost of drug development also might hamper the growth of the market. Bayer Healthcare, Sanofi, Anthera Pharmaceuticals and Ablynx are some of the companies operating in this market.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Revenue Predicted To Go Up by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Postmenopausal Osteoporosis Therapeutics Market Revenue Predicted To Go Up by 2015 to 2021

≪ Previous: Global Unstable Angina Therapeutics Market: Headed for Growth and Global Expansion by 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5879

The market of macular degeneration drugs can be segmented on the basis of available and upcoming drugs, such as Lucentis, Eylea, Avastin, Squalamine, Conercept, Lampalizamab and others. Moreover, the market can also be segmented on the basis of stage and type of AMD, such as early AMD, late AMD, dry AMD and wet AMD. Similarly, the market of diabetic retinopathy is also segmented on the basis of available and under pipeline products, such as Lucentis, Optina, Iluvien, Betamethazone, Ozurdex and others. The market can be also segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising markets in the upcoming period.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5879

The market for macular degeneration is driven by factors such as change in lifestyle, increased prevalence of various addictions, unhealthy diet, increase in elderly population of the world, and extensive R&D activities. Owing to strong emphasis on R&D, a large number of new drugs are under pipeline studies. The market of diabetic retinopathy is driven by increase in the prevalence of diabetes patients, increase in R&D practices and lack of awareness amongst the population about availability of the sophisticated treatments for diabetes. However, high cost of the R&D and lack of advanced technology in certain regions could act as hurdles for the growth of the market.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Postmenopausal Osteoporosis Therapeutics Market Revenue Predicted To Go Up by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Heart Implants Market: Revenue Predicted To Go Up by 2015 to 2021

≪ Previous: Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Revenue Predicted To Go Up by 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis.

View Sample Report @ http://www.persistencemarketresearch.com/samples/5882

Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/5882

Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure. Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Heart Implants Market: Revenue Predicted To Go Up by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Brachytherapy Devices Market Revenue Predicted To Go Up by 2015 to 2021

≪ Previous: Postmenopausal Osteoporosis Therapeutics Market Revenue Predicted To Go Up by 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing heart is replaced with healthier donor heart. Over the course of decades, many cutting-edge innovation took place to offer sound and reliable artificial cardiac devices. As per the WHO, heart disorder is one of the major cause of concern globally, killing more than 17.5 million people in 2012. It amounts to 31% of overall global deaths. Europe and Western Pacific are the prominent locations where mortality rate from heart disorders is scaling the peak. Heart implants is the lifesaving medium to improve the patients ailing conditions. Though the demand for heart implants is high, the supply is marginally low in the industry. As per the European Commissions Department of Health and Consumers, only 2,004 transplants were conducted against the need for 3,400 patients in 2012.

View Sample Report @ http://www.persistencemarketresearch.com/samples/6149

The heart implants market is expected to grow exponentially during the forecast period, primarily due to the changing lifestyle, fatal accidents, physical inactivity and prognosis of patients with heart failure leading to end-stage cardiac disorder are some of the key drivers of this market. High prevalence of cardiac disorders among middle class population is another significant driver for heart implants market. Though the market seems optimistic in coming years, shifting trends from heart-beating donations to non-heart beating procedures, high costs of devices along with stringent regulatory procedures in some of the key nations can led to some negative impact on this industry. However, this billion dollar industry is expected to witness upward trend during the forecast period 20152025, primarily due to rise in demand for heart implants.

Heart implants market is broadly classified on the basis of implant devices, implant procedure and cardiovascular disorders.

Different devices are used depending upon the types of cardiovascular disorders. Among all types of cardiovascular disorders, coronary heart disease is the one which claims more life than others. This is followed by peripheral atrial disease, rheumatic heart disease and congenital heart disease. While, coronary artery bypass, balloon angioplasty, valve replacement and heart transplantation are key implant procedure, implantable cardioverter defibrillator (ICD), pacemakers, cardiac resynchronization therapy (CRT), coronary stents, and peripheral stents are some of the key implant devices. ICD and CRT are the most popular types of implant devices, however, ICDs is anticipated to witness significant growth during the forecast period. New generation ICDs, are projected to capture the significant market share due to its dual ability of preventing heart from cardiac arrest as well as acting sometimes as pacemaker to make heart beat at proper rate and rhythm.

Most of the demands for heart implants is expected to generate from developed economies including North America and Europe. Increasing prevalence of heart related disorders, government focus towards providing reliable healthcare solution, increasing healthcare expenditure and key innovations driven by some of the major cardiac devices manufacturers in the region is expected to boost the overall sales of heart implants devices in North America and Europe. More than half of the demand for heart implants is expected to generate from North America and Europe. Asia Pacific is the next in trail. Increasing healthcare expenditure is one of the key driving factor in Asia Pacific. Compared to North America and Europe, Asia Pacific is relatively untapped market that needs to be capitalized and thus offers good market prospects for heart implant devices manufacturers.

Some of the key market players in heart implants market are Boston Scientific, Medtronic plc, St. Jude Medical, Inc., Angiotech Pharmaceuticals, Bard Incorporated and Carmat SA.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/6149

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Brachytherapy Devices Market Revenue Predicted To Go Up by 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Global Vascular Stents Market: Impact of Existing and Emerging Market 2015 to 2021

≪ Previous: Heart Implants Market: Revenue Predicted To Go Up by 2015 to 2021

(EMAILWIRE.COM, December 09, 2016 ) The global radiation therapy equipment market is classified into external radiation therapy equipment market and internal radiation therapy equipment market. Brachytherapy devices market is a sub segment under the internal radiation therapy equipment market. Brachytherapy is referred to as sealed source radiation therapy because the radiation source is sealed and placed inside or near the body part requiring radiation therapy. Besides the treatment of most body part tumors, brachytherapy is commonly used to treat the cancers of the cervix, breast, skin, and prostate. The radiation source is enclosed in a protective wire or a protective capsule and ionizing radiations escape to treat the surrounding cancerous tissues only while avoiding its effects on body fluids.

View Sample Report @ http://www.persistencemarketresearch.com/samples/6167

The advantage of brachytherapy devices over other forms of radiation therapy equipment is that it involves high precision in radiation source placement in the anatomy. One of the key features of brachytherapy devices is that they limit the radiation effects only to the local, diseased (tumors or cancers) parts of the anatomy. Hence, the healthy tissues are protected against radiation. Brachytherapy devices pave the way for a safe radiation therapy treatment in the presence of high, localized doses of radiation. The nature of brachytherapy devices makes it a durable form of treatment delivery as the re-occurrence of cancer in the patient treated with brachytherapy is rare. Brachytherapy is often used in combination with chemotherapy, surgery or external radiation therapy. Based on the location of the tumor being treated, brachytherapy devices market is restrained by a range of side-effects such as localized bleeding within implant region, urinary incontinence, desquamation, etc. The global brachytherapy devices market is expected to witness significant competition from the external radiation therapy equipment market that can hamper the growth of global brachytherapy devices market.

Brachytherapy Devices market is classified on the basis of the type of Product Types, dose rate, application, duration of treatment and geography.

The global brachytherapy devices market is anticipated to witness significant growth in the forecast years. The high-dose rate and low-dose rate of radiation in brachytherapy devices market together hold more than half the global brachytherapy devices market share. The global brachytherapy devices market is projected to grow at more than around 5% annually. The electronic brachytherapy device is a novel technology that is expected to add remarkable value to the global brachytherapy devices market and open a wide range of opportunities. The global brachytherapy devices market is largely dependent on the radiation sources used in brachytherapy such as cesium-137, cobalt-60, iridium-192, iodine-125, palladium-103, ruthenium-106 and radium-226.

Depending on geographic regions, global Brachytherapy Devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia-Pacific, Japan, and the Middle East & Africa. North America is the largest market for radiation therapy equipment followed by Europe due to the high incidence of cancer among the population in these regions. Asia Pacific is expected to be the most promising market for radiation therapy equipment owing to the improving healthcare infrastructure and affordable radiation therapy treatment. As of the regional outlook for brachytherapy devices market, the brachytherapy devices market is set to follow the trend of radiation therapy equipment market.

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/6167

Some of the key market players identified in global Brachytherapy Devices market are Elekta AB, Varian Medical Systems Inc. Eckert and Ziegler BEBIG S.A, and C.R. Bard.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Global Vascular Stents Market: Impact of Existing and Emerging Market 2015 to 2021

December 9, 2016, 12:00 am

≫ Next: Healthcare Nanotechnology (Nanomedicine) Market: Global Market Snapshot by 2015 to 2021

≪ Previous: Brachytherapy Devices Market Revenue Predicted To Go Up by 2015 to 2021

Persistence Market Research Pvt. Ltd

(EMAILWIRE.COM, December 09, 2016 ) Vascular Devices are used in the treatment of diseased blood vessel in heart and brain. Peripheral Arterial Disease (PAD) is the most common form of vascular disease which is characterized by the accumulation of plaque in the arteries which carrier blood from the heart to other parts of the body. Atherosclerosis is the primary indication for PAD globally. Other risk factors related to PAD include Smoking, High blood pressure, Diabetes and High cholesterol.

Peripheral Arterial Disease is most common in the lower extremity region. The diagnosis and treatment of PAD varies from individual to individual. Treatment of PAD can be performed surgically or by minimally invasive procedures. Use of the vascular stents is the usual and widely accepted form of treatment for PAD.

View Sample Report @ http://www.persistencemarketresearch.com/samples/6188

The global prevalence of PAD is around 3-12%. More than 200 million people globally are suffering from PAD. AS per CDC, approximately 8 million people in the United States have PAD, including 12-20% of individuals older than age 60.

With the aging population, there is a rising prevalence in the Peripheral Arterial Disease. PAD patients are at high risk for cardiovascular disease, with age affecting up to more than 20% of the patients. Stents manufacturers are continuously focusing on the technology and launching of new devices such as Drug-Eluting Stents as minimally invasive procedures are widely accepted across the globe.

Development in imaging techniques, there is significant improvement in accuracy and safety in vascular surgery implantations resulting in increase in the number of stenting procedures.

With rapid technological advancement and wide acceptance of stenting procedures among patients with PAD, the global vascular stents market is expected to witness a significant growth in the forecast period (2015-2025).

Depending on geographic regions, global vascular stents market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

North America dominates the global vascular stents market due to the significant spending power of large segments of the population and technological advancement. With the increase in procedure volumes and Europes healthy reimbursement system, this market is expected to experience a rapid growth. Asia-Pacific is the fastest emerging market for global vascular stents because the cost of surgery is reasonable as compared to other regions.

Some of the key market players in global laparoscopic devices market are Cordis Corporation, Abbott Vascular, Inc., Boston Scientific Corporation, C.R.Bard, Inc, Covidien Plc, Cook Medical and W.L. Gore & Associates

Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/6188

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com

Source: EmailWire.Com

↧

Latest Images